Home > Financial Ratios > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results

KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 45.4353.83-93.686.79-92.84

What is the latest Core EBITDA Growth ratio of KREBS BIOCHEMICALS & INDUSTRIES ?

The latest Core EBITDA Growth ratio of KREBS BIOCHEMICALS & INDUSTRIES is 45.43 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202445.43
Mar202353.83
Mar2022-93.68
Mar20216.79
Mar2020-92.84

How is Core EBITDA Growth of KREBS BIOCHEMICALS & INDUSTRIES Trending?

Years Core EBITDA Growth % Change
Mar2024 45.43
-15.60
Mar2023 53.83
Positive
Mar2022 -93.68
Negative
Mar2021 6.79
Positive
Mar2020 -92.84 -

Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES


Compare Core EBITDA Growth ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES ₹158.8 Cr -1.5% -11.7% -21.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹384,002.0 Cr -2.1% -5.8% -6.7% Stock Analytics
DIVIS LABORATORIES ₹164,334.0 Cr 3.1% -6.5% 28.7% Stock Analytics
CIPLA ₹127,613.0 Cr 2.2% 3.2% 1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,923.0 Cr -1.7% NA 9.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,437.0 Cr 1.4% -1.1% -7.6% Stock Analytics


KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES

-1.5%

-11.7%

-21.6%

SENSEX

-1.1%

-1.7%

-0.3%


You may also like the below Video Courses